An official website of the United States government
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
A Medicaid and CHIP state plan is an agreement between a state and the Federal government describing how that state administers its Medicaid and CHIP programs. It gives an assurance that a state will abide by Federal rules and may claim Federal matching funds for its program activities. The state plan sets out groups of individuals to be covered, services to be provided, methodologies for providers to be reimbursed and the administrative activities that are underway in the state.
When a state is planning to make a change to its program policies or operational approach, states send state plan amendments (SPAs) to the Centers for Medicare & Medicaid Services (CMS) for review and approval. States also submit SPAs to request permissible program changes, make corrections, or update their Medicaid or CHIP state plan with new information.
Persons with disabilities having problems accessing the SPA PDF files may call 410-786-0429 for assistance.
Summary: CMS approves Minnesota's time-limited COVID-19 disaster relief proposal. Effective March 1, 2020 per Section 7.4 of the Minnesota State Plan, the Minnesota State Medicaid agency waives signature requirements for the dispensing of drugs during the Federal COVID-19 Public Health Emergency.
Summary: CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency. In this amendment Minnesota elects to (1) waive cost sharing for COVID-19 testing and treatment, (2) suspend disenrollment due to failure to pay premiums for working disabled BBA group, (3) expand telehealth, and (4) to allow for 90-day refills without prior authorization for certain maintenance drugs.
Summary: Updates the state plan to include utilization from participating MCOs for supplemental drug rebates for direct-acting antivirals for the treatment of hepatitis C.
Summary: This amendment proposes to revise the state plan to cover the dispensing of over the counter drugs in a nursing facility through the use of an automated dispensing system.
Summary: Expands access to medication therapy management services and allows physician assistants to provide medication management services in outpatient setting.
Summary: This amendment proposes to revise payment rates and coverage for 3408 drugs and proposes to allow prescribers to indicate the need to dispense a brand name drug using an electronic alternative to hand writing.
Summary: This Amendment proposed changes in pharmacy coverage required by Section 175 of the Medicare Improement for Patients and Oroviders Act of 2008 which amended section 1860D-2 (e) 2 (A) of the Act in include barbiturates" used in the treatment of epilepsy, cancer, or chronic mental health disorder" and benzodiazepines in Part D drug coverage.
